Prevalence of coexisting diseases in patients with Alzheimer's disease

Geriatrics and Gerontology International

Volumn 10, Issue 2, 2010, Pages 216-217

  Sakurai, Hirofumi ^a   Hanyu, Haruo ^a   Kanetaka, Hidekazu ^a   Sato, Tomohiko ^a   Shimizu, Soichiro ^a   Hirao, Kentaro ^a   Iwamoto, Toshihiko ^a  

^a TOKYO MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ALZHEIMER DISEASE; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; DIABETES MELLITUS; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSLIPIDEMIA; ELDERLY CARE; HUMAN; HYPERTENSION; JAPAN; LETTER; LIFESTYLE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ALZHEIMER DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; JAPAN; PREVALENCE;

EID: 77952523665     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2010.00609.x     Document Type: Letter

References (12)

1. Doraiswamy PM, Leon J, Cummings JL. Prevalence and impact of medical comorbidity in Alzheimer's disease. J Gerontol A Biol Sci Med Sci 2002, 57:M173-M177.
2. Boksay I, Boksay E, Reisberg B. Alzheimer's disease and medical disease conditions: a prospective cohort study. J Am Geriatr Soc 2005, 53:2235-2236.
3. McKhann G, Drachman D, Folstein M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health & Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
4. Roman GC, Tatemichi TK, Erkinjuntti T. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop. Neurology 1993, 43:250-260.
5. McKeith IG, Dickson DW, Lowe J. Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium. Neurology 2005, 65:1863-1872.
6. Petersen RC, Smith GE, Waring SC. Mild Cognitive Impairment: clinical characterization and outcome. Arch Neurol 1999, 56:303-308.
7. Report of the Expert Committtee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997, 20:1183-1197. The Expert Committtee on the diagnosis and Classification of Diabetes Mellitus
8. Miida T, Takahashi A, Tanabe N, Ikeuchi T. Can statin therapy really reduce the risk of Alzheimer's disease and slow its progression. Curr Opin Lipidol 2005, 16:619-623.
9. Helzner EP, Luchsinger JA, Scarmeas N. Contribution of vascular risk factors to the progression in Alzheimer disease. Arch Neurol 2009, 66(3):343-348.
10. Shimizu K, Hirose N, Takayama M. Relationship between physical and cognitive function, blood pressure and serum lipid concentration in centenarians. Geriatr Gerontol Int 2008, 8:300-302.
11. McCormic WC, Kukull WA, Van Belle G. Symptom patterns and comorbidity in the early stages of Alzheimer's disease. J Am Geriatr Soc 1994, 42:517-521.
12. Araki A, Ito H. Diabetes mellitus and geriatric syndromes. Geriatr Gerontol Int 2009, 9:105-114.